Effect of Vupanorsen on Non–High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70

四分位间距 医学 安慰剂 内科学 载脂蛋白B 胆固醇 他汀类 内分泌学 高密度脂蛋白 脂蛋白 胃肠病学 病理 替代医学
作者
Brian Bergmark,Nicholas Marston,Candace Bramson,M. Curto,Vesper Ramos,Alexandra Jevne,Julia Kuder,Jeong‐Gun Park,Sabina A. Murphy,Subodh Verma,Wojciech Wojakowski,Steven G. Terra,Marc S. Sabatine,Stephen D. Wiviott,Diane Carbonneau,Raphael Poulin-Robitaille,Jeffrey D. Wayne,Keung Lee,Samuel Mujica Trenche,Petros Dzongowski,Daniel Gaudet,Joanna Van,Dilawar Ajani,Harold Bays,John O’Mahony,Adam Janas,John Scott,Moustafa Ashraf Moustafa,Thomas Ransom,Sabrina Benjamin,Naresh Aggarwal,Paweł Bogdański,Douglas G Friars,Robert Schlosser,Bogusław Okopień,Madhusudan Budhraja,Lawrence Feld,Leslie J. Klaff,Guy Tellier,Giuseppe Mazza,I Wierzbicka,Ewa Jazwinska-Tarnawska,Fernando Boccalandro,Julio Rosenstock,Elizabeth Marquez,Kim Barbel-Johnson,Katarzyna Madziarska,K W Heaton,Jean‐Claude Tardif,John Rubino,Miguel Á. Treviño,Katie Moriarty,Anil Gupta,Wojciech Wojakowski,James L. Fidelholtz,Dhiraj Gupta,Hani Al‐Asaad,Shane Christensen,Parag K Shah,Stephanie Li,Mark Sherman,Andre Frechette,Cecilia Arango,Alan Egan,Sunny Srivastava,Archna Bajaj,Carlos Ince,Aleksander Żurakowski
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:145 (18): 1377-1386 被引量:90
标识
DOI:10.1161/circulationaha.122.059266
摘要

Genetic loss-of-function variants in ANGPTL3 are associated with lower levels of plasma lipids. Vupanorsen is a hepatically targeted antisense oligonucleotide that inhibits Angiopoietin-like 3 (ANGPTL3) protein synthesis.Adults with non-high-density lipoprotein cholesterol (non-HDL-C) ≥100 mg/dL and triglycerides 150 to 500 mg/dL on statin therapy were randomized in a double-blind fashion to placebo or 1 of 7 vupanorsen dose regimens (80, 120, or 160 mg SC every 4 weeks, or 60, 80, 120, or 160 mg SC every 2 weeks). The primary end point was placebo-adjusted percentage change from baseline in non-HDL-C at 24 weeks. Secondary end points included placebo-adjusted percentage changes from baseline in triglycerides, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (ApoB), and ANGPTL3.Two hundred eighty-six subjects were randomized: 44 to placebo and 242 to vupanorsen. The median age was 64 (interquartile range, 58-69) years, 44% were female, the median non-HDL-C was 132.4 (interquartile range, 118.0-154.1) mg/dL, and the median triglycerides were 216.2 (interquartile range, 181.4-270.4) mg/dL. Vupanorsen resulted in significant decreases from baseline over placebo in non-HDL-C ranging from 22.0% in the 60 mg every 2 weeks arm to 27.7% in the 80 mg every 2 weeks arm (all P<0.001 for all doses). There were dose-dependent reductions in triglycerides that ranged from 41.3% to 56.8% (all P<0.001). The effects on LDL-C and ApoB were more modest (7.9%-16.0% and 6.0%-15.1%, respectively) and without a clear dose-response relationship' and only the higher reductions achieved statistical significance. ANGPTL3 levels were decreased in a dose-dependent manner by 69.9% to 95.2% (all P<0.001). There were no confirmed instances of significant decline in renal function or platelet count with vupanorsen. Injection site reactions and >3× elevations of alanine aminotransferase or aspartate aminotransferase were more common at higher total monthly doses (up to 33.3% and 44.4%, respectively), and there was a dose-dependent increase in hepatic fat fraction (up to 76%).Vupanorsen administered at monthly equivalent doses from 80 to 320 mg significantly reduced non-HDL-C and additional lipid parameters. Injection site reactions and liver enzyme elevations were more frequent at higher doses, and there was a dose-dependent increase in hepatic fat fraction.URL: https://clinicaltrials.gov; Unique identifier: NCT04516291.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ZSH完成签到,获得积分10
刚刚
Litoivda完成签到 ,获得积分10
2秒前
暮雨完成签到,获得积分10
3秒前
DOGDAD完成签到,获得积分10
5秒前
英俊的铭应助温柔翰采纳,获得10
5秒前
英姑应助薛建伟采纳,获得10
5秒前
如云完成签到,获得积分20
6秒前
你说的完成签到 ,获得积分10
6秒前
Jasper应助大脸猫4811采纳,获得10
7秒前
hearz完成签到,获得积分10
8秒前
9秒前
P2JY完成签到,获得积分10
9秒前
leiiiiiiii完成签到,获得积分10
9秒前
Bake完成签到 ,获得积分10
11秒前
12秒前
yuan完成签到,获得积分10
12秒前
论文多多完成签到,获得积分10
13秒前
13秒前
Acid完成签到 ,获得积分10
13秒前
1111111111111发布了新的文献求助10
14秒前
linlinyilulvdeng完成签到,获得积分10
14秒前
斯文败类应助历史雨采纳,获得10
15秒前
FashionBoy应助吃个大笼包采纳,获得10
17秒前
海阔天空发布了新的文献求助10
18秒前
薛建伟发布了新的文献求助10
19秒前
高高代珊发布了新的文献求助10
20秒前
害羞的墨镜完成签到,获得积分10
20秒前
lalala发布了新的文献求助10
20秒前
21秒前
guojingjing完成签到,获得积分10
21秒前
打打应助科多兽骑士采纳,获得10
22秒前
angela完成签到,获得积分10
22秒前
22秒前
潇洒的茗茗完成签到 ,获得积分10
24秒前
脂肪小米粥完成签到,获得积分10
25秒前
小幸运完成签到,获得积分10
28秒前
爱吃冻梨完成签到,获得积分10
28秒前
xiang发布了新的文献求助10
28秒前
陈冲冲完成签到,获得积分10
29秒前
changfox完成签到,获得积分10
29秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038657
求助须知:如何正确求助?哪些是违规求助? 3576306
关于积分的说明 11375198
捐赠科研通 3306108
什么是DOI,文献DOI怎么找? 1819379
邀请新用户注册赠送积分活动 892698
科研通“疑难数据库(出版商)”最低求助积分说明 815066